{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:48:35Z","timestamp":1793321315222,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xphs.2025.103971","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T23:12:48Z","timestamp":1755904368000},"page":"103971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A multifunctional 64+67Cu-pyrazolone complex: Green synthesis, radiolabeling, molecular docking, and tumor-targeted theranostic evaluation"],"prefix":"10.1016","volume":"114","author":[{"given":"Hesham A.","family":"Shamsel-Din","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-5714","authenticated-orcid":false,"given":"Moaz M.","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa A.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9390-9103","authenticated-orcid":false,"given":"Mohamed A.","family":"Gizawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2025.103971_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"10.1016\/j.xphs.2025.103971_bib0002","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0003","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40001-023-01627-0","article-title":"Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation","volume":"29","author":"Dhoundiyal","year":"2024","journal-title":"Eur J Med Res."},{"issue":"8","key":"10.1016\/j.xphs.2025.103971_bib0004","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","article-title":"Radiotheranostics in oncology: current challenges and emerging opportunities","volume":"19","author":"Bodei","year":"2022","journal-title":"Nature Rev Clinic Oncol"},{"issue":"11","key":"10.1016\/j.xphs.2025.103971_bib0005","doi-asserted-by":"crossref","DOI":"10.2533\/chimia.2000.683","article-title":"Radiopharmaceuticals for targeted tumor diagnosis and therapy","volume":"54","author":"Waibel","year":"2000","journal-title":"Chimia"},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct Target Therapy"},{"key":"10.1016\/j.xphs.2025.103971_bib0007","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10967-010-0455-2","article-title":"Synthesis and biodistribution of a novel 99mTc-DMSA-metronidazole ester as a potential tumor hypoxia imaging agent","volume":"283","author":"Zhang","year":"2010","journal-title":"J Radioanal Nucl Chem"},{"issue":"23","key":"10.1016\/j.xphs.2025.103971_bib0008","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.3390\/molecules24234314","article-title":"Development of targeted alpha particle therapy for solid tumors","volume":"24","author":"Tafreshi","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.xphs.2025.103971_bib0009","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1021\/acsptsci.1c00035","article-title":"Lipophilicity determines routes of uptake and clearance, and toxicity of an alpha-particle-emitting peptide receptor radiotherapy","volume":"4","author":"Tafreshi","year":"2021","journal-title":"ACS Pharmacol Translat Sci"},{"issue":"6","key":"10.1016\/j.xphs.2025.103971_bib0010","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.7150\/thno.96675","article-title":"Theranostics-a sure cure for cancer after 100 years?","volume":"14","author":"Song","year":"2024","journal-title":"Theranostics"},{"issue":"23","key":"10.1016\/j.xphs.2025.103971_bib0011","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1039\/c0dt01504k","article-title":"Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS","volume":"40","author":"R\u00f6sch","year":"2011","journal-title":"Dalton Trans"},{"key":"10.1016\/j.xphs.2025.103971_bib0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5005\/jp-journals-10028-1054","article-title":"A bridge not too far: personalized medicine with the use of Theragnostic Radiopharmaceuticals","volume":"47","author":"Srivastava","year":"2013","journal-title":"J Postgrad Med Educ Res"},{"key":"10.1016\/j.xphs.2025.103971_bib0013","article-title":"State of the art and future perspectives of new radionuclides in Nuclear medicine. Part II","author":"Sancho","year":"2025","journal-title":"Revista Espa\u00f1ola De Medicina Nuclear E Imagen Molecul (Eng Edit)"},{"key":"10.1016\/j.xphs.2025.103971_bib0014","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fmed.2019.00124","article-title":"Clinical results in medullary thyroid carcinoma suggest high potential of pretargeted immuno-PET for tumor imaging and theranostic approaches","volume":"6","author":"Bodet-Milin","year":"2019","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.xphs.2025.103971_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/ract-2018-3070","article-title":"Feasibility study on production of Sc-47 from neutron irradiated Ca target for cancer theranostics applications","volume":"108","author":"Gizawy","year":"2020","journal-title":"Radiochim Acta"},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/138161207779313768","article-title":"Copper chelation chemistry and its role in copper radiopharmaceuticals","volume":"13","author":"Wadas","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.xphs.2025.103971_bib0017","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.3390\/ijms24119154","article-title":"Recent advances in 64Cu\/67Cu-based radiopharmaceuticals","volume":"24","author":"Krasnovskaya","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2025.103971_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2023.111096","article-title":"Green synthesis, radioiodination and in vivo biodistribution of 5-(2-hydroxyphenyl)-2, 4-dihydro-3H-pyrazol-3-one derivatives as potential candidates for lung imaging","volume":"203","author":"Abdou","year":"2024","journal-title":"Appl Radiat Isotop"},{"key":"10.1016\/j.xphs.2025.103971_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112406","article-title":"Review of anticancer potentials and structure-activity relationships (SAR) of rhodanine derivatives","volume":"145","author":"Yin","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.xphs.2025.103971_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400470","article-title":"A review of recent advances in anticancer activity and SAR of pyrazole derivatives","volume":"358","author":"Hofny","year":"2025","journal-title":"Arch Pharm"},{"issue":"17","key":"10.1016\/j.xphs.2025.103971_bib0021","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cellul Molecul Life Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.2011.648617","article-title":"Targeting the EGFR signaling pathway in cancer therapy","volume":"16","author":"Seshacharyulu","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.xphs.2025.103971_bib0023","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejmech.2016.09.025","article-title":"Synthesis and in vitro characterization of novel fluorinated derivatives of the translocator protein 18 kDa ligand CfO-DPA-714","volume":"125","author":"Cacheux","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.xphs.2025.103971_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103840","article-title":"Newly reported alkaloids produced by marine-derived penicillium species (covering 2014\u20132018)","volume":"99","author":"Zhang","year":"2020","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.xphs.2025.103971_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2023.108769","article-title":"Separation of 64+67Cu (II) from irradiated natural zinc target by sodium alginate-polyacrylic acid\/nanohalloysite composite","volume":"191","author":"Gizawy","year":"2023","journal-title":"Microchemic J"},{"issue":"17","key":"10.1016\/j.xphs.2025.103971_bib0026","first-page":"5205","article-title":"Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes","volume":"49","author":"Boswell","year":"2004","journal-title":"J Med Chem."},{"issue":"2","key":"10.1016\/j.xphs.2025.103971_bib0027","first-page":"157","article-title":"Development and evaluation of [64Cu] Cu-DOTATATE for clinical applications","volume":"31","author":"Zolghadri","year":"2023","journal-title":"Iran J Nuclear Med"},{"key":"10.1016\/j.xphs.2025.103971_bib0028","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10967-012-1885-9","article-title":"Preparation, nano purification, quality control and labeling optimization of [64Cu]-5, 10, 15, 20-tetrakis (penta fluoro phenyl) porphyrin complex as a possible imaging agent","volume":"295","author":"Fazaeli","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.xphs.2025.103971_bib0029","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00775-015-1318-7","article-title":"Promising bifunctional chelators for copper 64-PET imaging: practical 64Cu radiolabeling and high in vitro and in vivo complex stability","volume":"21","author":"Wu","year":"2016","journal-title":"JBIC J Biologic Inorgan Chem"},{"issue":"2","key":"10.1016\/j.xphs.2025.103971_bib0030","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/cr3003104","article-title":"Radiometals for combined imaging and therapy","volume":"113","author":"Cutler","year":"2013","journal-title":"Chem Rev."},{"issue":"8","key":"10.1016\/j.xphs.2025.103971_bib0031","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jlcr.3841","article-title":"A novel 99mTc-diester complex as tumor targeting agent: synthesis, radiolabeling, and biological distribution study","volume":"63","author":"Shamsel-Din","year":"2020","journal-title":"J Labelled Compound Radiopharmaceut"},{"issue":"24","key":"10.1016\/j.xphs.2025.103971_bib0032","first-page":"2893","article-title":"Production and applications of copper-64 in radiopharmaceuticals","volume":"10","author":"Sun","year":"2004","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.xphs.2025.103971_bib0033","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10967-020-07385-1","article-title":"Molecular docking and preliminary bioevaluation of 99mTc-Thiadiazuron as a novel potential agent for cervical cancer imaging","volume":"326","author":"Shamsel-Din","year":"2020","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.xphs.2025.103971_bib0034","first-page":"1","article-title":"Design, synthesis, biological evaluation, and molecular docking studies of novel azo-compounds derivatives as significant antioxidants","volume":"2023","author":"Elsayed","year":"2023"},{"issue":"5","key":"10.1016\/j.xphs.2025.103971_bib0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/molecules23051209","article-title":"Novel structural insight into inhibitors of heme oxygenase-1 (HO-1) by new imidazole-based compounds: biochemical and in vitro anticancer activity evaluation","volume":"23","author":"Greish","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0036","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/157340611794072698","article-title":"Docking and molecular dynamics study on the inhibitory activity of novel inhibitors on epidermal growth factor receptor (EGFR)","volume":"7","author":"Liao","year":"2011","journal-title":"Med Chem"},{"issue":"2","key":"10.1016\/j.xphs.2025.103971_bib0037","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4067\/S0717-97072021000205149","article-title":"Approaches for chemical synthesis and diverse pharmacological significance of pyrazolone derivatives: a review","volume":"66","author":"Asif","year":"2021","journal-title":"J Chilean Chemic Soc"},{"key":"10.1016\/j.xphs.2025.103971_bib0038","unstructured":"Verdicchio, F. (2023). Pyrazolone-based metal complexes: synthesis, characterization and theoretical study of Zn (II), Cu (II) and Mo (IV) derivatives."},{"key":"10.1016\/j.xphs.2025.103971_bib0039","first-page":"3024","volume":"8","author":"Yepremyan","year":"2018"},{"key":"10.1016\/j.xphs.2025.103971_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215459","article-title":"Copper pyrazole complexes as potential anticancer agents: evaluation of cytotoxic response against cancer cells and their mechanistic action at the molecular level","volume":"498","author":"Ghorbanpour","year":"2024","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.xphs.2025.103971_bib0041","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c02885","article-title":"Radiocopper in radiopharmacy and medical use: current status and perspective","author":"Kr\u0119cisz","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.xphs.2025.103971_bib0042","first-page":"1","article-title":"Two new square-planar Cu (II) complexes derived from a heterocyclic pyrazolone ligand: synthesis, in vitro anticancer activity, DFT and Hirshfeld analysis","author":"Barad","year":"2025","journal-title":"Transit Metal Chem"},{"key":"10.1016\/j.xphs.2025.103971_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127603","article-title":"Copper complexes of pyrazolone-based Schiff base ligands: synthesis, crystal structures and antibacterial properties","volume":"1205","author":"Poormohammadi","year":"2020","journal-title":"J Mol Struct"},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/jbes.2023.372066","article-title":"Conventional and microwave-assisted synthesis, anticancer and antimicrobial evaluation of some new pyrazolone, pyrazole and pyrimidine derivatives","volume":"10","author":"Anwer","year":"2023","journal-title":"J Basic Environment Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75173-8","article-title":"Apoptotic effect of novel pyrazolone-based derivative [Cu (PMPP-SAL)(EtOH)] on HeLa cells and its mechanism","volume":"10","author":"Reheman","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.xphs.2025.103971_bib0046","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2478\/acph-2020-0040","article-title":"Antitumor effect of a pyrazolone-based complex [Cu (PMPP-SAL)(EtOH)] against murine melanoma B16 cell in vitro and in vivo","volume":"70","author":"Abula","year":"2020","journal-title":"Acta Pharmaceutica"},{"issue":"9","key":"10.1016\/j.xphs.2025.103971_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22860","article-title":"Microwave-assisted synthesis of hybrid PABA-1, 3, 5-triazine derivatives as an antimalarial agent","volume":"35","author":"Kashyap","year":"2021","journal-title":"J Biochem Mol Toxicol."},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0048","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/s41598-024-51708-1","article-title":"CuO nanoparticles for green synthesis of significant anti-Helicobacter pylori compounds with in silico studies","volume":"14","author":"Shehab","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2025.103971_bib0049","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65166-2","article-title":"Pharmacokinetic and molecular docking studies to pyrimidine drug using Mn3O4 nanoparticles to explore potential anti-alzheimer activity","volume":"14","author":"Shehab","year":"2024","journal-title":"Sci Rep"},{"issue":"41","key":"10.1016\/j.xphs.2025.103971_bib0050","article-title":"Design, synthesis, docking, 2D-QSAR modelling, anticancer and antioxidant evaluation of some new azo-compounds derivatives and investigation of their fluorescence properties","volume":"7","author":"Hamed","year":"2022","journal-title":"Chem Select"},{"issue":"10","key":"10.1016\/j.xphs.2025.103971_bib0051","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1142\/S1088424620500352","article-title":"Radiosynthesis, molecular modeling and biodistribution of 99mTc-protoporphyrin as a preclinical model for tumor diagnosis","volume":"24","author":"Gizawy","year":"2020","journal-title":"J Porphyr Phthalocyanines"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:02:49Z","timestamp":1769713369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022354925004253"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103971","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multifunctional 64+67Cu-pyrazolone complex: Green synthesis, radiolabeling, molecular docking, and tumor-targeted theranostic evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103971"}}